Progressive Myopia clinical trials

Explore recruiting progressive myopia clinical trials.

Recruiting progressive myopia studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Progressive Myopia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Low-dose AtropIne for Myopia control in children

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Investigator led, double-masked, multicentre, randomized clinical trial for the comparison of atropine 0.5% versus atropine 0.05% eye drops for the prevention of myopia progression in Dutch children

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

A phase III, randomized, double-masked, placebocontrolled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine Sulfate 0.01%) in treating the progression of myopia in pediatric subjects

Ireland, Slovakia, Hungary, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Progressive Myopia trials by city

Progressive Myopia in Toronto Progressive Myopia in Vancouver Progressive Myopia in Montreal Progressive Myopia in Calgary Progressive Myopia in Edmonton Progressive Myopia in Ottawa Progressive Myopia in Winnipeg Progressive Myopia in Quebec City Progressive Myopia in Hamilton Progressive Myopia in Kitchener Progressive Myopia in London Progressive Myopia in Halifax Progressive Myopia in New York Progressive Myopia in Los Angeles Progressive Myopia in Chicago Progressive Myopia in Houston

Progressive Myopia clinical trials

Recruiting progressive myopia studies right now

Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children.

Myopia Control Combined PBM With Myopic Defocus Lens in Children

MAD Trial: Myopia Atropine Dose

Clinical Efficacy and Mechanism Exploration of MR-61 in Delaying the Progression of Myopia

Myopia Preventing With Distance-image Screen

Also recruiting in Europe

Low-dose AtropIne for Myopia control in children

Investigator led, double-masked, multicentre, randomized clinical trial for the comparison of atropine 0.5% versus atropine 0.05% eye drops for the prevention of myopia progression in Dutch children

A phase III, randomized, double-masked, placebocontrolled, parallel-group, multicenter study of the safety and efficacy of OT-101 (Atropine Sulfate 0.01%) in treating the progression of myopia in pediatric subjects

Progressive Myopia trials by city

Other conditions